
View larger version (89K):
[in this window]
[in a new window]
|
Fig. 2. Cell fate specification, timing of differentiation and tissue
architecture are unchanged in Wnt7b-null lungs. (A-D')
E14.5 immunohistochemistry of heterozygous (A-D) and Wnt7b mutant
(A'-D') mouse lungs. Blood vessels appear normal in the mutant, as
marked by PECAM (A,A'), as does airway smooth muscle, marked by smooth
muscle myosin (B,B'). Proximal Sox2 (C,C') and distal Sox9
(D,D') expression are unchanged in mutants. Dotted lines encircle the
epithelium. (E-I') At E18.5, immunohistochemistry of heterozygous (E-I)
and Wnt7b mutant (E'-I') lungs demonstrates that blood
vessels (E,E'), airway smooth muscle cells (F,F'), Clara cells as
marked by CC10 (G,G'), and type 2 cells as marked by surfactant protein
C (H,H') are unchanged in mutant lungs. Type 1 cells marked by caveolin
1 (I,I') are decreased in number. (J) Quantification of cell
types in E18.5 lungs demonstrates that the proportions of Clara, ciliated and
mucous cells are unchanged in the trachea and airways of Wnt7b
mutants. In the distal saccules, the proportions of cells positive for SP-C or
PECAM are also unchanged. Error bars represent 1 s.d. (K) The number of
Sox9-positive cells per lung bud tip at E14.5 is unchanged in Wnt7b
mutants.
|